MENLO PARK, Calif., Nov. 4, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect…
DELRAY BEACH, Fla., Nov. 4, 2024 /PRNewswire/ -- The global AI in pathology market is projected to reach USD 169.8 million…
Volpara's Patient Hub™ will deliver advanced mammography reporting and risk assessment to enhance breast cancer screening across military health facilitiesLYNNWOOD,…
Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studiesCollaboration underscores Lonza's commitment to…
HOUSTON, Nov. 4, 2024 /PRNewswire/ -- OncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of Elite Cancer…
Epic now fully supports version 3 of the United States Core Data for Interoperability standards—over a year ahead of the…
Segment featuring leading Neuro-Oncologist and Glioblastoma Key Opinion Leader, Professor Michael WellerAccess the segment here HOUSTON, TX / ACCESSWIRE /…
Garden City, New York--(Newsfile Corp. - November 4, 2024) - Silberstein, Awad & Miklos, P.C. (ASK4SAM), a prominent Bronx-based medical…
Adult patients with breast cancer are a prespecified subgroup of the recently conducted OnTarget trial evaluating crofelemer for prophylaxis of…
Experienced CFO and investment banker with 30-year track record will help drive CureVac's transformationTÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE…